The SKC conferences are free to attend, bringing families together with the research and healthcare communities to learn about the latest in neuroblastoma research, and to share their experiences. Through insightful talks and discussions, as well as the opportunity to put questions to the experts, the conferences aim to inform families and empower their discussion making.

Registration is open

Standard Registration closes on January 24, 2025

Registration is open until 15th January 2025

Registration is open until full capacity or until November 10th, whichever occurs first.

See more

Vilnius – the capital of Lithuania is the city situated on the boundary of two ancient – Latin and Byzantine – civilizations. People from all the different nationalities, religions and cultures lived here and have created a colorful city mosaic. Vilnius has one of the largest Old Towns in Central and Eastern Europe where the buildings of different styles and the network of medieval streets are very well preserved. The Old Town of Vilnius is part of the UNESCO World Heritage List.

This meeting brings together the diverse stakeholders involved in facing key issues for children and adolescents with cancer. The SIOP Europe Annual Meeting provides a unique interactive format to discuss the current priorities and needs in the field of childhood cancers.

Hotels

Maps

Transportation in Vienna

This important event which brings together about 200 members from 34 European countries offer updates on on-going trials, results, and work in progress by the various subspecialty committees, scientific presentations, specific sessions for young investigators, encounters with patient advocates and sessions for case discussions. For the second time SIOPEN will award the best oral and poster presentation.

Facing the Acropolis at the Royal Olympic Hotel from 12 to 14 of October we presented, discussed and decided on the new prognostic markers, the results of our treatments, upcoming protocols in Europe and the US, new modes of therapies to follow the end of the current treatments, the long-term sequelae and how these can be ameliorated, as well as, issues of supportive care and palliative measures.